Target intelligence / Profile preview

Mesenchymal stem cell-mediated paracrine signaling (MSC-mediated paracrine signaling)

Target
MSC-mediated paracrine signaling
Molecular classification
Other
01

Overview

Mesenchymal stem cell-mediated paracrine signaling refers to the process by which mesenchymal stem cells secrete bioactive molecules—such as growth factors, cytokines, chemokines, extracellular vesicles including exosomes—that act on neighboring cells. This secretion modulates immune responses by promoting anti-inflammatory macrophage polarization and regulatory T-cell induction. It also supports tissue repair through enhanced angiogenesis and inhibition of inflammatory pathways. The overall effect helps restore homeostasis in damaged tissues and has therapeutic potential in conditions like osteoarthritis and other inflammatory or degenerative diseases. The mechanism involves complex interactions between multiple secreted factors rather than targeting a single receptor or enzyme.[1][2][3]

Other names
Paracrine effect of mesenchymal stem cellsMSC secretome-mediated effectsMesenchymal stromal cell-derived paracrine signaling
02

Mechanism of action

Not applicable as this is not a drug target per se; however, mechanisms include secretion of soluble factors such as prostaglandin E2 (PGE2), indoleamine 2,3-dioxygenase (IDO), exosomes containing microRNAs and proteins that modulate immune responses and promote tissue repair.

03

Biological functions

Immune regulationTissue repair and regenerationModulation of inflammationAngiogenesis
04

Disease associations

OsteoarthritisInflammation-related diseasesTissue injury-related diseases (e.g., cardiovascular disease, ischemic injury)
05

Safety considerations

General safety concerns relate to potential immunogenicity or off-target effects when using MSCs themselves rather than their secretomeUsing purified secretome reduces some risks such as genotoxicity associated with long-term cell culture
06

Biomarkers

Inflammatory cytokines like IL-10Macrophage polarization markers

Beyond the preview

Go deeper on Mesenchymal stem cell-mediated paracrine signaling (MSC-mediated paracrine signaling).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesenchymal stem cell-mediated paracrine signaling (MSC-mediated paracrine signaling).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call